Romina Estefanía Nieto

Featured in: Favicon

Articles

Finding the Role of Anifrolumab in the New Paradigm of Systemic Lupus Erythematosus Treatment

Nov 1, 2024 | jrheum.org | Graciela S. Alarcón |Laurent Arnaud |Guillermo Javier Pons-Estel |Romina Estefanía Nieto

The article by Tani et al, “Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter Study,”1 evaluates the efficacy of anifrolumab (ANI) in patients with systemic lupus erythematosus (SLE) who failed to respond to other treatments, including biologics. There are many unmet needs in the treatment of SLE.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.